Semaglutida es un medicamento para bajar de peso que acta como agonista del receptor GLP1, estimulando pptidos similares al glucagn en el cuerpo para promover la prdida de peso y revertir la diabetes tipo 2
Who Is a Candidate for Weekly GLP-1 Injections and Safety Considerations GLP-1 therapy is typically appropriate for adults with BMI 27 kg/m with weight-related comorbidities or BMI 30 kg/m regardless of comorbidities
Accessed July 4, 2025
In a previous study, researchers treated mice with a vitamin D-enriched diet and observed an increase in Klotho expression (112)
While these side effects can be mildly disruptive to daily routines, they are considered normal while on Trulicity and are generally tolerable to most patients
Nathan A, Rossin EJ, Kaseke C, Park RJ, Khatri A, Koundakjian D, et al